Proposed biochemistry of Parkinson's and Alzheimer's diseases

被引：7
|
作者：
Robertson, D. S. [1 ]
机构：
[1] 205 Pickersleigh Rd, Malvern WR14 2QS, Worcs, England
来源：
MEDICAL HYPOTHESES | 2017年 / 109卷
关键词：
Betaines; Monatomic oxygen; Parkinson's disease; Alzheimer's disease; FLUID NITRATE LEVELS; CEREBROSPINAL-FLUID; QUINOLINIC ACID; SERUM FERRITIN; IRON; PLASMA; TRANSFERRIN; KYNURENINE; ALS;
D O I：
10.1016/j.mehy.2017.08.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The formation of brain compounds linked to Parkinson's and Alzheimer's brain diseases are described. Metabolic mechanisms involved in the control of reacting biochemicals are detailed. Relationships are established between the biochemical reactions, biochemical control mechanisms and the onset of Parkinson's, Alzheimer's. Treatments based on these relationships are proposed.
引用
收藏
页码：131 / 138
页数：8
相关论文
共 50 条
  • [31] Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases
    Braak, Heiko
    Rueb, Udo
    Schultz, Christian
    Del Tredici, Kelly
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 : 35 - 44
  • [32] Facial emotion expressivity in Parkinson's and Alzheimer's diseases
    Cannavacciuolo, A.
    Colella, D.
    Salzillo, M.
    De Biase, A.
    Paparella, G.
    Canevelli, M.
    Bruno, G.
    Berardelli, A.
    Berardelli, A.
    Bologna, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 437 - 437
  • [33] Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases
    Hernando, Sara
    Gartziandia, Oihane
    Herran, Enara
    Luis Pedraz, Jose
    Igartua, Manoli
    Maria Hernandez, Rosa
    NANOMEDICINE, 2016, 11 (10) : 1267 - 1285
  • [34] Parkinson's and Alzheimer's diseases - Protein aggregations and neuroprotection
    Gozes, I
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (03) : 333 - 336
  • [35] Lymphocytes: model of study in Alzheimer's and Parkinson's diseases
    Jimenez Del Rio, Marlene
    Velez-Pardo, Carlos
    IATREIA, 2006, 19 (01) : 47 - 61
  • [36] Impaired Neurotransmitter Release in Alzheimer's and Parkinson's Diseases
    Shen, Jie
    NEURODEGENERATIVE DISEASES, 2010, 7 (1-3) : 80 - 83
  • [37] The aging immune system in Alzheimer's and Parkinson's diseases
    Heavener, Kelsey S.
    Bradshaw, Elizabeth M.
    SEMINARS IN IMMUNOPATHOLOGY, 2022, 44 (05) : 649 - 657
  • [38] Oligomeropathies and Pathogenesis of Alzheimer and Parkinson's Diseases
    Forloni, Gianluigi
    Artuso, Vladimiro
    La Vitola, Pietro
    Balducci, Claudia
    MOVEMENT DISORDERS, 2016, 31 (06) : 771 - 781
  • [39] Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's
    Nirale, Prabhuti
    Paul, Ankita
    Yadav, Khushwant S.
    LIFE SCIENCES, 2020, 245
  • [40] Naming in dementia secondary to Parkinson's, Huntington's, and Alzheimer's diseases
    Frank, EM
    McDade, HL
    Scott, WK
    JOURNAL OF COMMUNICATION DISORDERS, 1996, 29 (03) : 183 - 197
12345